Applied Opt (AAOI) had the highest return between June 1, 2023 and December 31, 2023 by a US stock with a market cap of $300M to $10B, returning 782.2%.
| ASSET | DATE | % RETURN |
|---|---|---|
Applied Opt (AAOI) | 6/1/2023 - 12/31/2023 | 782.19% |
Soleno Therapeutics (SLNO) | 6/1/2023 - 12/31/2023 | 662.31% |
Gyre Therapeutics (GYRE) | 6/1/2023 - 12/31/2023 | 613.61% |
Spyre Therapeutics (SYRE) | 6/1/2023 - 12/31/2023 | 562.15% |
QXO (QXO) | 6/1/2023 - 12/31/2023 | 471.18% |
MoneyLion (ML) | 6/1/2023 - 12/31/2023 | 467.33% |
ASP Isotopes Inc Common Stock (ASPI) | 6/1/2023 - 12/31/2023 | 466.46% |
Eyepoint Pharmaceuticals (EYPT) | 6/1/2023 - 12/31/2023 | 281.35% |
Tango Therapeutics (TNGX) | 6/1/2023 - 12/31/2023 | 269.4% |
Scholar Rock (SRRK) | 6/1/2023 - 12/31/2023 | 220.82% |
Silence Therapeutics (SLN) | 6/1/2023 - 12/31/2023 | 215.82% |
Pharvaris (PHVS) | 6/1/2023 - 12/31/2023 | 209.94% |
BridgeBio Pharma (BBIO) | 6/1/2023 - 12/31/2023 | 192.32% |
Ramaco Resources (METC) | 6/1/2023 - 12/31/2023 | 192.1% |
United States Cellular (USM) | 6/1/2023 - 12/31/2023 | 188.47% |
Abercrombie & Fitch (ANF) | 6/1/2023 - 12/31/2023 | 187.08% |
Belite Bio Inc ADR (BLTE) | 6/1/2023 - 12/31/2023 | 184.87% |
Telephone and Data Systems (TDS) | 6/1/2023 - 12/31/2023 | 184.43% |
Rhythm Pharmaceuticals (RYTM) | 6/1/2023 - 12/31/2023 | 177.93% |
Altimmune (ALT) | 6/1/2023 - 12/31/2023 | 177.09% |
GigaCloud Technology Inc Class A Ordinary Shares (GCT) | 6/1/2023 - 12/31/2023 | 174.7% |
Frequency Therapeutics (KRRO) | 6/1/2023 - 12/31/2023 | 173.89% |
Gap (GAP) | 6/1/2023 - 12/31/2023 | 173.35% |
Olema Pharmaceuticals (OLMA) | 6/1/2023 - 12/31/2023 | 170.85% |
Blend Labs (BLND) | 6/1/2023 - 12/31/2023 | 160.2% |
